Pre-Treatment Tumor Expression of ERCC1 in Women with Advanced Stage Epithelial Ovarian Cancer is Not Predictive of Clinical Outcomes: A Gynecologic Oncology Group Study

OBJECTIVE: Excision repair cross-complementation group 1 (ERCC1) is required for the repair of platinum-induced DNA damage. This study sought to assess the prognostic value of ERCC1 expression, measured by immunohistochemistry (IHC) using a highly specific antibody, in advanced epithelial ovarian ca...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Rubatt, Jennifer M., Darcy, Kathleen M., Tian, Chunqiao, Muggia, Franco, Dhir, Rajiv, Armstrong, Deborah K., Bookman, Michael A., Niedernhofer, Laura J., Deloia, Julie, Birrer, Michael, Krivak, Thomas Carl
Format: Artigo
Langue:Inglês
Publié: 2012
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3490188/
https://ncbi.nlm.nih.gov/pubmed/22261301
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ygyno.2012.01.008
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires